The Global Adipose-Derived Stem Cell Market Research Report published by Emergenresearch has been formulated by analysis of key business details and extensive geographical spread of the Adipose-Derived Stem Cell industry. The study offers comprehensive coverage of the qualitative and quantitative analysis of the Adipose-Derived Stem Cell market along with crucial statistical data about the Adipose-Derived Stem Cell market. The research study provides historical data from 2017 to 2018 and offers accurate forecast estimation until 2027. The report also profiles established and emerging players of the market, covering the business overview, product portfolio, strategic alliances, and business expansion strategies.
Adipose-derived stem cells (ASCs) are mesenchymal stem cells that are present abundantly in adipose tissues and can be differentiated into different cell lineages. Owing to its ability of self-renewal and ability to differentiate into different cell lineages has increased their application in clinical trials of regenerative medicine. ASCs can be harvested in large number from adipose tissues by a minimally invasive procedure, thereby increasing their potential for regenerating tissues and organs damaged by severe injury or chronic diseases. ASCs are widely used for cell-based therapy and in combination with biomaterials or drugs to accelerate the treatment process.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/203
Key companies in the market include Allocure, Inc., Celgene Corporation, Pluristem Therapeutics, Inc., Intrexon, Inc., Celleris SA, Tissue Genesis, Inc., Mesoblast, Ltd., Antaria, Inc. Thermo Fisher Scientific, Inc., American CryoStem, and Merck KGaA.
The latest report is the most recent study that offers 360° coverage of the Adipose-Derived Stem Cell industry that has been facing the brunt of the adverse economic impact of the COVID-19 outbreak since the beginning of this year. The global health crisis has affected nearly every aspect of the business vertical and led to massive disruptions to the global Adipose-Derived Stem Cell market demand and supply chains. Researchers draw predictions for the market scenario in the post-COVID era. The report, additionally, assesses the present market situation and estimates its future outcomes, keeping in mind the impact of the pandemic on the global economic landscape.
For the purpose of this report, Emergen Research has segmented the global adipose-derived stem cell market on the basis of cell type, product type, disease indication, end-use industries, application, and region:
Cell Type Outlook (Revenue, USD Billion; 2018–2028)
- Allogenic
- Autologous
Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Cell Line
- Culture Media
- Media
- Sera
- Reagents
Disease Indication Outlook (Revenue, USD Billion; 2018–2028)
- Cancer
- Obesity
- Wounds Injuries
- Cardiovascular Diseases
- Musculoskeletal
End-use Industries Outlook (Revenue, USD Billion; 2018–2028)
- Cell Banks Tissue Banks
- Research Laboratories Academic Institutes
- Hospitals Trauma Centers
- Others
Application Outlook (Revenue, USD Billion; 2018–2028)
- Therapeutic
- Research
- Others
Request customization of the report: https://www.emergenresearch.com/request-for-customization/203
The report offers a comprehensive overview of the competitive landscape and covers company profiles, production and manufacturing capacity, product portfolio, expansion strategies, and business initiatives such as mergers and acquisitions, joint ventures, collaborations, partnerships, and product launches and brand promotions among others.
Some Key Highlights in the Report:
Allogenic stem cells segment to account for largest revenue share in the global market over the forecast period owing to increasing application of allogenic stem cells in various cell-based therapies and rising availability of stem cell therapy products based on allogenic stem cells.
Musculoskeletal diseases segment is expected to register significant revenue growth over the forecast period owing to increasing prevalence of musculoskeletal disorders and increasing application of regenerative medicine to treat bone and joint diseases.
Research application segment is expected to register robust revenue CAGR over the forecast period owing to increasing investment and funding to advance stem cell research and accelerate development of cell-based therapeutic products.
North America is expected to account for largest revenue share between 2021 and 2028 owing to rising private and public funding, increasing number of research activities, financial support from government to accelerate stem cell research, increasing incidence of musculoskeletal and bone and joint disorders, and presence of key players in the region.
In September 2021, BioRestorative Therapies, Inc. announced that it had received a patent for its metabolic ThermoStem Program from the Australian Patient Office.
- Report Overview
1.1 Research Scope
1.2 Key Adipose-Derived Stem Cell market segments
1.3 Major players
1.4 Market analysis by product
1.5 Market analysis by application
1.6 Report timeline - Global Growth Trends
2.1 Global Adipose-Derived Stem Cell market size
2.2 Latest Adipose-Derived Stem Cell market trends
2.3 Key growth trends - Competitive Landscape
3.1 Global Adipose-Derived Stem Cell market key players
3.2 Global Adipose-Derived Stem Cell size by manufacturers
3.3 Products of major players
3.4 Entry barriers in the Adipose-Derived Stem Cell market
3.5 Mergers, acquisitions, joint ventures, and strategic alliances
Regional Overview:
The global Adipose-Derived Stem Cell market has been categorized on the basis of key geographical regions into North America, Asia Pacific, Europe, Latin America, and Middle East Africa. It evaluates the presence of the global Adipose-Derived Stem Cell market in the major regions with regards to market share, market size, revenue contribution, sales network and distribution channel, and other key elements.
Read More: https://www.emergenresearch.com/industry-report/adipose-derived-stem-cell-market
Related Reports:
pharmacogenomics market
womens health market
https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/womens-health-market
mammography system market
smart contact lens market
biomaterials market
https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/biomaterials-market
biophotonics market
https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/biophotonics-market
crispr technology market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
"
